Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High-Content and Phenotypic Screening Europe 2018

Giovanna Defilippi's Biography



Giovanna Defilippi, Sr. Field Applications Scientist, Axion BioSystems

Dr Giovanna De Filippi joined Axion BioSystems in March 2018 as Senior Field Applications Scientist for Europe and provides technical support for their complete line of products. Dr De Filippi holds a Ph.D. in Physiological Sciences from the University of Milan, Italy, with a focus on neuroscience research and electrophysiological techniques. In her career she has gained 10 years’ experience in neuroscience research and pre-clinical drug discovery within the pharmaceutical industry and 10 years’ experience in scientific and commercial roles in the instrumentation industry serving the life sciences and material sciences markets. Dr De Filippi has a wide understanding of customer needs in both scientific and business settings. Prior to her position with Axion BioSystems, she held positions as a senior research scientist at Eli Lilly and Company in UK, as applications and support manager for a scanning probe microscopy company and as a technical sales and customer support for manufacturers and distributors of surface metrology, spectroscopy and electrochemical instrumentation bridging life and material sciences.

Giovanna Defilippi Image

Get Ready to LEAP: Advances in Automated Arrhythmia Detection for Next-Generation hiPSC-CM MEA Assays

Thursday, 24 May 2018 at 17:00

Add to Calendar ▼2018-05-24 17:00:002018-05-24 18:00:00Europe/LondonGet Ready to LEAP: Advances in Automated Arrhythmia Detection for Next-Generation hiPSC-CM MEA AssaysHigh-Content and Phenotypic Screening Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

Trends in cardiac safety testing, as exemplified by CiPA and JiCSA, emphasize a move beyond surrogate measures of proarrhythmia. The cardiomyocyte and multiwell microelectrode array (CM-MEA) assay offers an ideal approach to evaluate pre-arrhythmic indicators in vitro. Join Axion BioSystems to discuss the new Local Extracellular Action Potential (LEAP) for next-generation CM-MEA assays. The LEAP assay allows you to record extracellular action potential waveforms and characterize repolarization irregularities (e.g. EADs), label-free and in real-time.


Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonHigh-Content and Phenotypic Screening Europe 2018High-Content and Phenotypic Screening Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com